Literature DB >> 18632811

Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2.

Ryosuke Arakawa1, Masaki Okumura, Hiroshi Ito, Chie Seki, Hidehiko Takahashi, Harumasa Takano, Ryuji Nakao, Kazutoshi Suzuki, Yoshiro Okubo, Christer Halldin, Tetsuya Suhara.   

Abstract

UNLABELLED: (S,S)-18F-FMeNER-D2 was recently developed as a radioligand for the measurement of norepinephrine transporter imaging with PET. In this study, a norepinephrine transporter was visualized in the human brain using this radioligand with PET and quantified by several methods.
METHODS: PET scans were performed on 10 healthy men after intravenous injection of (S,S)-18F-FMeNER-D2. Binding potential relative to nondisplaceable binding (BP(ND)) was quantified by the indirect kinetic, simplified reference-tissue model (SRTM), multilinear reference-tissue model (MRTM), and ratio methods. The indirect kinetic method was used as the gold standard and was compared with the SRTM method with scan times of 240 and 180 min, the MRTM method with a scan time of 240 min, and the ratio method with a time integration interval of 120-180 min. The caudate was used as reference brain region.
RESULTS: Regional radioactivity was highest in the thalamus and lowest in the caudate during PET scanning. BP(ND) values by the indirect kinetic method were 0.54 +/- 0.19 and 0.35 +/- 0.25 in the thalamus and locus coeruleus, respectively. BP(ND) values found by the SRTM, MRTM, and ratio methods agreed with the values demonstrated by the indirect kinetic method (r = 0.81-0.92).
CONCLUSION: The regional distribution of (S,S)-18F-FMeNER-D2 in our study agreed with that demonstrated by previous PET and postmortem studies of norepinephrine transporter in the human brain. The ratio method with a time integration interval of 120-180 min will be useful for clinical research of psychiatric disorders for estimation of norepinephrine transporter occupancy by antidepressants without requiring arterial blood sampling and dynamic PET.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632811     DOI: 10.2967/jnumed.108.051292

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

1.  Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates.

Authors:  Jean-Dominique Gallezot; David Weinzimmer; Nabeel Nabulsi; Shu-Fei Lin; Krista Fowles; Christine Sandiego; Timothy J McCarthy; R Paul Maguire; Richard E Carson; Yu-Shin Ding
Journal:  Neuroimage       Date:  2010-09-30       Impact factor: 6.556

2.  Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.

Authors:  Gunasingh J Masilamoni; James W Bogenpohl; David Alagille; Kristen Delevich; Gilles Tamagnan; John R Votaw; Thomas Wichmann; Yoland Smith
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

3.  Compartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brain.

Authors:  Vikram Adhikarla; Fanxing Zeng; John R Votaw; Mark M Goodman; Jonathon A Nye
Journal:  Nucl Med Biol       Date:  2016-02-28       Impact factor: 2.408

4.  Unravelling the effects of methylphenidate on the dopaminergic and noradrenergic functional circuits.

Authors:  Ottavia Dipasquale; Daniel Martins; Arjun Sethi; Mattia Veronese; Swen Hesse; Michael Rullmann; Osama Sabri; Federico Turkheimer; Neil A Harrison; Mitul A Mehta; Mara Cercignani
Journal:  Neuropsychopharmacology       Date:  2020-05-30       Impact factor: 7.853

5.  Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2.

Authors:  Mizuho Sekine; Ryosuke Arakawa; Hiroshi Ito; Masaki Okumura; Takeshi Sasaki; Hidehiko Takahashi; Harumasa Takano; Yoshiro Okubo; Christer Halldin; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2010-03-23       Impact factor: 4.530

6.  Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2).

Authors:  Akihiro Takano; Balázs Gulyás; Andrea Varrone; Ralph Paul Maguire; Christer Halldin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-20       Impact factor: 9.236

7.  Dopamine, but not serotonin, regulates reversal learning in the marmoset caudate nucleus.

Authors:  Hannah F Clarke; Gemma J Hill; Trevor W Robbins; Angela C Roberts
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

8.  The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.

Authors:  Thomas Vanicek; Marie Spies; Christina Rami-Mark; Markus Savli; Anna Höflich; Georg S Kranz; Andreas Hahn; Alexandra Kutzelnigg; Tatjana Traub-Weidinger; Markus Mitterhauser; Wolfgang Wadsak; Marcus Hacker; Nora D Volkow; Siegfried Kasper; Rupert Lanzenberger
Journal:  JAMA Psychiatry       Date:  2014-12-01       Impact factor: 21.596

9.  Central nervous system drug evaluation using positron emission tomography.

Authors:  Mizuho Sekine; Jun Maeda; Hitoshi Shimada; Tsuyoshi Nogami; Ryosuke Arakawa; Harumasa Takano; Makoto Higuchi; Hiroshi Ito; Yoshiro Okubo; Tetsuya Suhara
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-04-30       Impact factor: 2.582

10.  Automated radiosynthesis of two 18F-labeled tracers containing 3-fluoro-2-hydroxypropyl moiety, [18F]FMISO and [18F]PM-PBB3, via [18F]epifluorohydrin.

Authors:  Takayuki Ohkubo; Yusuke Kurihara; Masanao Ogawa; Nobuki Nengaki; Masayuki Fujinaga; Wakana Mori; Katsushi Kumata; Masayuki Hanyu; Kenji Furutsuka; Hiroki Hashimoto; Kazunori Kawamura; Ming-Rong Zhang
Journal:  EJNMMI Radiopharm Chem       Date:  2021-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.